VA ECMO update - sepseostrava.cz · Chest pain, anterior STEMI, BP of 70/50 mmHg, defibrillated for...
Transcript of VA ECMO update - sepseostrava.cz · Chest pain, anterior STEMI, BP of 70/50 mmHg, defibrillated for...
VA ECMO update
Jan Bělohlávek, ECMO team Prague
Complex cardiovascular center
General University Hospital, 1st Medical Faculty
Charles University in Prague
Indikace ECMO
• Těžké kardiální a/nebo respirační selhání
• Rezistentní kardiogenní šok
• Srdeční zástava, akcidentální hypotermie
• ARDS, selhání štěpu po Tx, reperfuzní edém po
PEA, H1N1
• Respirační selhání u novorozenců
• Elektivní podpora: PCI, RFA, kardiochirurgie
Schwarz B, Crit Care Med 2003; Hemmila,, Annals of Surgery 2004; Bakhtiary F, J Thorac Cardiovasc Surg 2008; Ravi R, Ann
Thorac Surg 2009;Arlt M, Resuscitation 2008; Gregoric ID, J Heart Lung Transplant. 2008; Marasco SF, Heart Lung Circ 2008;
Fiser S, Ann Thorac Surg 2001; Marasco , J Heart Lung Transplant 2005; Asaumi Y, Eur Heart J 2005; Scaife ER, J Pediatr
Surg 2007; J Thorac Cardiovasc Surg 2007; Resuscitation 2009; Pereszlenyi A, Eur J Cardiothorac Surg 2002; Aigner, Eur J
Cardiothorac Surg 2007; Hsu HH, J Heart Lung Transplant 2008; Berman M, Ann Thoac Surg 2008; Peek GJ, CESAR trial.
Lancet. 2009; Horton S, Perfusion 2004; Camboni D, Interact Cardiovasc Thorac Surg 2009; Booth KL, JACC 2002
Typy indikací
• Bridge to bridge
• Bridge to decision
• Bridge to recovery
• Bridge to transplant
• Bridge to destination therapy
• Bridge to „nowhere“
Počet případů a hospitalizační mortalita vs. doba na
ECMO
In hospital mortalita
u vv- a va-ECMO vs. věk
VA ECMO update – setting
• cardiogenic shock • stand-by
– fast recovery possible or expected
– dry-primed ECLS + perfusionist with coffee in the cathlab
– femoral artery and vein for eventual ecmo cannulated with standard
sheats
• implantation
– rapidly crashing…
– withour expected fast recovery (immediate PCI, prompt
improvement on catecholamines)
• cardiac arrest • OHCA/IHCA….in house/out of house
• septic shock?
Overall, 34.6% died
during VA ECMO,
37.9% died after
weaning,
26.5% discharged.
Hospital volume not associated with
mortality.
4 kohortové studie – 235 pacientů s CS po AMI O 33% vyšší 30-denní přežití vs. IABP, ale žádný rozdíl pro TandemHeart/Impella 10 studií se srdeční zástavou – 3098 pacientů O 13% vyšší 30-denní přežití (NNT 7.7) a o 14% vyšší výskyt norm. neurol. výsledku (NNT 7.1)
VERY VERY high risk PCI
EP studies (sustained VT with hemodynamic compromise)
TAVI
ECMO support
during interventions – elective cases
O2
pump
oxygenator
V-A
Femoro-femoral
Fem. Art.
IVC
Peripheral ECMO
A profile of patients treated by ECMO. Bělohlávek et al. Interv Acut Cardiol2010; 9(3): 121–
128
O2
pump
oxygenator
subcl./axil.
art.
IVC
V-A
Femoro-
subclavian/axillary
A profile of patients treated by ECMO. Bělohlávek et al. Interv Acut Cardiol2010; 9(3): 121–
128
Peripheral ECMO
ECMO and LV interaction (1)
ECMO > LV ECMO ≈ LV ECMO < LV
Ostadal, Belohlavek. ECMO manual, 2013
ECMO
LV
LV LV
• increasing EBF in cardiogenic shock during
peripheral VA ECMO impairs LV performance
in a flow dependent manner
• optimal VA ECMO flow should be as low as
possible to sustain adequate tissue perfusion
ECMO is circulatory
support, not LV support!
7/32 survivors
VA ECMO for septic shock
– good for children
and adults with severe septic
cardiomyopathy
VA ECMO
• standard of care
• as a circulatory support for
cardiogenic and septic shock
• for refractory cardic arrest - ECPR
• current evidence controversial
• needs randomized studies
Extracorporeal CPR
• continuation in CPR using mechanical
circulatory support
• always VA-ECMO
Source: GUH Prague
Cardiac arrest in OHCA 50-70/100.000 annually
• CPR registries
• INTCAR registry
• TTM trial
succesfull ROSC patients !!!
30-40%
Where are the 60-70% remaining?
Refractory cardiac arrest 10…16….30 minutes ???
Favorable outcome of ≈ 2-4%
Fagnoul et al., Curr Opin Crit Care 2014
Grunau et al., Prehosp Emerg Care 2016
Dying…
ECPR studies in OHCA
Author Year of
publication
N Time to
ECMO (min)
Survival
Nagao 2000 36 67 25 %
Haneya 2012 26 70 15 %
Kagawa 2012 42 59 24 %
Nagao 2010 171 66 12 %
Le Guen 2011 51 120 4%
Avalli 2012 18 77 6 %
Fagnoul 2013 53 66 21 %
Maekawa 2013 53 49 32 %
Leick 2013 28 44 39 %
SAVE-J Sakamoto 2014 260 - 12 %
CHEER 2014 11 Impl. 20 27%
Choi 2016 320 54 9%
Prague OHCA randomized S vs. H 2016 65 (29) 56 (Impl. 14) 28 %
An „optimal“ patient for ECPR
• refractory cardiac arrest (>16 min)
• no comorbidities
• witnessed cardiac arrest
– EMS
– public place
• assumption of correctable cause (ACS)
• shockable rhythm (VF/VT)
• intermittent ROSC
Prerequsites for ECPR
• resuscitation team
• 24/7 (15 min) available ECMO team
(intensivist/cardiologist/perfusionist/surgeon?)
• close cooperation with EMS in cases of OHCA
• early alert system for ECMO/cathlab teams
• be able to admitt and cath under ongoing CPR (mechanical CPR)
• monitor brain tissue saturations (NIRS)
• immediatelly available ABG/ECHO/vascular US
• primed ECMO device on cathlab/ER 24/7
Initial prehospital care
Witnessed cardiac arrest
Telephone assisted bystander CPR
EMS crew
dispatched
EMS dispatch center
ALS > 5 min
CA > 15-20 min
Call to cardiac center
Check for eligibility
If no ROSC
Early SMS alert
to cardiac center
ECMO team
capacity confirmed
„Hyperinvasive“ approach to refractory OHCA
• early alert to cardiac center
• mechanical chest compressions LUCAS
• intra-arrest cooling RhinoChill
• extracorporeal life support ECMO
• neuromonitoring NIRS-INVOS
• immediate invasive assesment CAG/PCI
and treatment
PuAG
SMS
Guidelines ERC 2015
Extracorporeal Cardiopulmonary Resuscitation (eCPR)
Extracorporeal CPR (eCPR) should be considered as a
rescue therapy for those patients in whom initial ALS
measures are unsuccessful and, or to facilitate specific
interventions (e.g. coronary angiography and percutaneous
coronary intervention (PCI) or pulmonary thrombectomy for
massive pulmonary embolism).
Hyperinvasive approach uses ECPR
as a one of several stepwise interventions
within changed
prehospital and early hospital logistics
ECPR - conclusion
• rescue method for refractory cardiac arrest • refractory VF/VT
• witnessed cardiac arrest
• intermittent ROSC
• recommended in ERC 2015 guidelines
• crucial to continue in randomized studies
• organ donorship as a byproduct
Clinical consequencies
• Not ECLS alone,
but „comprehensive approach“ including ECLS may
have an impact on logistics for OHCA patients
• patients who need ECLS for refractory OHCA
have often severe unresolvable cause
• we have technology, now we have to find right
patients and optimize logistics.
• future? • EPR – emergency preservation and resuscitation
» Drabek et al., 2014
Is it ethical to put a patient on a device
to extend CPR?
• uncertain risk-benefit profile
• inability to obtain informed consent
• high cost
• Grave prognosis
• Potential Harms
• Failed recovery….“bridge to nowhere“
• prolonged ICU stay
• Judge: averting death with ECPR may foreclose
the chance for „good death“
Riggs, Resuscitation 2015
ARDS (acute respiratory distress syndrome)
• typ akutního, difuzního, zánětlivého poškození
plic, které vede ke zvýšení plicní vaskulární
permeability, zvýšení váhy plic a ztrátě vzdušnosti
• Morfologické známky
– difuzní alveolární poškození
• edém, zánět, hyalinní blanky nebo krvácení
• Klinické známky
– hypoxémie a bilaterální plicní infiltráty
– větší mrtvý prostor
– snížená compliance plic
„Lung rest setting“
• Peak insp. pressure 20-25 cmH2O
• PEEP 10-15 cmH20
• FiO2 30%
• Frekvence 10/min
oxygenátor
rotaflow řídící
jednotka a pumpa
rotaflow konzole
ECMO – PLS/Cardiohelp (Maquet)
Ohřívač/chladič
Typy ECMO
V-A
• oběhová (BiV) podpora
• respirační podpora
• totální nebo parciální
• smíchávání toků v aortě
• žilní a arteriální kanylace
• pokles preloadu
• mírný vzestup afterloadu
• zvýšení „wall stresu“ LK
• přetížení LK
– plicní hypoperfuze
– riziko trombózy LS/LK
V-V
• podpora respiračních
funkcí
• podmínkou je uspokojivá
funkce LK i PK
• jen žilní kanylace
• 2x single/double lumen
• riziko recirkulace
• minimální efekt na CVP,
plnění PK, LK a celkovou
hemodynamiku
• systémová hemodynamika
je na VV-ECMO nezávislá!
O2
pumpa
oxygenátor
VJI
ddž
Femoro-jugulární
V-V ECMO okruh
Profil pacientů léčených ECMO. Bělohlávek et al. Interv Akut Kardiol 2010; 9(3): 121–128